Aveanna Healthcare Holdings Inc. (AVAH) Financial Ratios
8 years of historical data (2018–2025) · Healthcare · Medical - Care Facilities
EV/EBITDA
↓
9.04
↓-64% vs avg
5yr avg: 25.00
30Y Low10.0·High51.5
P/FCF
↓
11.63
↓-56% vs avg
5yr avg: 26.24
30Y Low13.8·High34.2
P/B Ratio
↑
7.67
↑+39% vs avg
5yr avg: 5.54
30Y Low2.1·High8.9
ROE
↑
621.9%
↓+382% vs avg
5yr avg: 129.0%
30Y Low-209%·High-14%
Debt/EBITDA
↓
4.65
↓-74% vs avg
5yr avg: 17.57
30Y Low4.6·High45.9
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
AVAH Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Aveanna Healthcare Holdings Inc. trades at 6.6x earnings, 14% below its 5-year average of 7.7x, sitting at the 0th percentile of its historical range. Compared to the Healthcare sector median P/E of 22.3x, the stock trades at a discount of 70%. On a free-cash-flow basis, the stock trades at 11.6x P/FCF, 56% below the 5-year average of 26.2x.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $1.5B | $1.7B | $899M | $509M | $145M | $1.4B | — | — | — |
| Enterprise Value | $2.6B | $2.9B | $2.3B | $2.0B | $1.5B | $2.6B | — | — | — |
| P/E Ratio → | 6.61 | 7.70 | — | — | — | — | — | — | — |
| P/S Ratio | 0.60 | 0.71 | 0.44 | 0.27 | 0.08 | 0.81 | — | — | — |
| P/B Ratio | 7.67 | 8.93 | — | — | — | 2.14 | — | — | — |
| P/FCF | 11.63 | 13.80 | 34.15 | 30.75 | — | — | — | — | — |
| P/OCF | 11.63 | 13.80 | 27.54 | 22.45 | — | — | — | — | — |
P/E links to full P/E history page with 30-year chart
AVAH EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
Aveanna Healthcare Holdings Inc.'s enterprise value stands at 9.0x EBITDA, 64% below its 5-year average of 25.0x. The Healthcare sector median is 14.4x, placing the stock at a 37% discount on an enterprise-value basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 1.19 | 1.14 | 1.04 | 0.83 | 1.57 | — | — | — |
| EV / EBITDA | 9.04 | 9.98 | 13.55 | 51.46 | — | — | — | — | — |
| EV / EBIT | 9.85 | 11.51 | 14.83 | 216.55 | — | — | — | — | — |
| EV / FCF | — | 22.94 | 88.02 | 118.65 | — | — | — | — | — |
AVAH Profitability
Margins and return-on-capital ratios measuring operating efficiency
Aveanna Healthcare Holdings Inc. earns an operating margin of 10.9%. Operating margins have expanded from 0.4% to 10.9% over the past 3 years, signaling improving operational efficiency. Return on equity of 621.9% is exceptionally high, though this is partly amplified by negative book value driven by aggressive share buybacks. ROIC of 15.1% represents solid returns on invested capital.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 33.1% | 33.1% | 31.4% | 31.4% | 30.9% | 32.3% | 30.4% | 30.3% | 31.5% |
| Operating Margin | 10.9% | 10.9% | 6.9% | 0.4% | -35.9% | -2.2% | -0.2% | 2.8% | 3.1% |
| Net Profit Margin | 9.2% | 9.2% | -0.5% | -7.1% | -37.0% | -7.0% | -3.8% | -5.5% | -3.8% |
Return on Capital
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| ROE | 621.9% | 621.9% | — | — | -208.9% | -25.9% | -21.2% | -24.8% | -13.7% |
| ROA | 12.2% | 12.2% | -0.7% | -8.1% | -32.7% | -5.6% | -3.3% | -4.9% | -3.0% |
| ROIC | 15.1% | 15.1% | 8.0% | 0.5% | -29.8% | -1.7% | -0.2% | 2.2% | 2.3% |
| ROCE | 18.6% | 18.6% | 11.1% | 0.6% | -38.1% | -2.0% | -0.2% | 2.8% | 2.9% |
AVAH Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
Aveanna Healthcare Holdings Inc. carries a Debt/EBITDA ratio of 4.6x, which is highly leveraged (41% above the sector average of 3.3x). Net debt stands at $1.2B ($1.3B total debt minus $193M cash). Interest coverage of just 1.9x is concerning — the company has limited headroom to absorb earnings volatility before struggling with debt service.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 6.91 | 6.91 | — | — | — | 2.04 | 4.60 | 3.98 | 2.76 |
| Debt / EBITDA | 4.65 | 4.65 | 8.79 | 39.28 | — | — | 45.94 | 16.37 | 18.69 |
| Net Debt / Equity | — | 5.91 | — | — | — | 1.99 | 4.08 | 3.97 | 2.74 |
| Net Debt / EBITDA | 3.98 | 3.98 | 8.29 | 38.13 | — | — | 40.81 | 16.32 | 18.53 |
| Debt / FCF | — | 9.14 | 53.87 | 87.90 | — | — | 10.76 | — | 468.24 |
| Interest Coverage | 1.89 | 1.89 | 0.89 | 0.05 | -5.96 | -0.52 | -0.04 | 0.42 | 0.52 |
AVAH Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
A current ratio of 1.32x means Aveanna Healthcare Holdings Inc. can comfortably meet its short-term obligations, though there is limited excess liquidity. The current ratio has improved from 0.89x to 1.32x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.32 | 1.32 | 0.98 | 0.89 | 0.83 | 0.81 | 1.31 | 1.11 | 1.08 |
| Quick Ratio | 1.32 | 1.32 | 0.98 | 0.89 | 0.83 | 0.81 | 1.31 | 1.11 | 1.08 |
| Cash Ratio | 0.46 | 0.46 | 0.21 | 0.12 | 0.06 | 0.09 | 0.53 | 0.02 | 0.04 |
| Asset Turnover | — | 1.21 | 1.22 | 1.17 | 1.04 | 0.72 | 0.81 | 0.88 | 0.81 |
| Inventory Turnover | — | — | — | — | — | — | — | — | — |
| Days Sales Outstanding | — | 47.01 | 50.06 | 47.34 | 46.07 | 48.99 | 44.16 | 43.33 | 53.12 |
AVAH Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Aveanna Healthcare Holdings Inc. does not currently pay a dividend and has no material buyback yield, reinvesting earnings back into the business. The earnings yield of 15.1% (inverse of P/E) provides a useful comparison to bond yields when assessing the stock's relative attractiveness to fixed income.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — |
Total Shareholder Return Metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 15.1% | 13.0% | — | — | — | — | — | — | — |
| FCF Yield | 8.6% | 7.2% | 2.9% | 3.3% | — | — | — | — | — |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — | — | — |
| Total Shareholder Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — | — | — |
| Shares Outstanding | — | $215M | $193M | $190M | $186M | $185M | $186M | $186M | $180M |
Peer Comparison
Compare AVAH with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 AVAHYou | $1B | 6.6 | 9.0 | 11.6 | 33.1% | 10.9% | 621.9% | 15.1% | 4.6 |
 PNTG | $1B | 42.5 | 28.0 | 47.2 | 12.9% | 5.4% | 8.6% | 5.6% | 7.6 |
 ADUS | $2B | 18.7 | 12.5 | 17.5 | 32.5% | 9.7% | 9.3% | 8.8% | 1.3 |
 HCSG | $2B | 27.5 | 22.4 | 11.5 | 13.0% | 2.6% | 11.7% | 9.0% | 0.4 |
 ENSG | $10B | 29.8 | 25.7 | 27.5 | 13.7% | 8.6% | 16.9% | 7.0% | 7.7 |
 MMS | $4B | 12.1 | 6.7 | 9.9 | 23.0% | 10.6% | 18.1% | 15.1% | 2.0 |
 OPCH | $3B | 16.3 | 7.4 | 12.6 | 18.1% | 6.0% | 15.2% | 15.3% | — |
 BFAM | $4B | 20.3 | 13.1 | 14.6 | 23.6% | 10.7% | 14.8% | 8.0% | 4.3 |
 UNH | $336B | 27.9 | 16.7 | 20.9 | 18.5% | 4.2% | 11.8% | 9.2% | 3.4 |
 CVS | $111B | 62.8 | 13.1 | 14.3 | 13.8% | 2.6% | 2.3% | 5.0% | 6.2 |
 HUM | $30B | 25.1 | 16.9 | 79.1 | 14.5% | 1.1% | 7.0% | 4.1% | 5.7 |
| Healthcare Median | — | 22.3 | 14.4 | 18.5 | 63.9% | -5.2% | -33.7% | -11.2% | 3.3 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 8 years · Updated daily
See AVAH's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs AVAH Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare AVAH vs PNTG
Side-by-side business, growth, and profitability comparison vs The Pennant Group, Inc..
Start ComparisonAVAH — Frequently Asked Questions
Quick answers to the most common questions about buying AVAH stock.
What is Aveanna Healthcare Holdings Inc.'s P/E ratio?
Aveanna Healthcare Holdings Inc.'s current P/E ratio is 6.6x. The historical average is 7.7x.
What is Aveanna Healthcare Holdings Inc.'s EV/EBITDA?
Aveanna Healthcare Holdings Inc.'s current EV/EBITDA is 9.0x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 25.0x.
What is Aveanna Healthcare Holdings Inc.'s ROE?
Aveanna Healthcare Holdings Inc.'s return on equity (ROE) is 621.9%. This is above the typical threshold of 15-20% considered good for most companies. The historical average is -58.9%.
Is AVAH stock overvalued?
Based on historical data, Aveanna Healthcare Holdings Inc. is trading at a P/E of 6.6x. Compare with industry peers and growth rates for a complete picture.
What are Aveanna Healthcare Holdings Inc.'s profit margins?
Aveanna Healthcare Holdings Inc. has 33.1% gross margin and 10.9% operating margin. Operating margin between 10-20% is typical for established companies.
How much debt does Aveanna Healthcare Holdings Inc. have?
Aveanna Healthcare Holdings Inc.'s Debt/EBITDA ratio is 4.6x, indicating high leverage. A ratio above 4x may signal elevated financial risk.